Different markers were used to identify TAMs in CRC, and CD68 had been widely recommended as a pan-macrophage marker, making this protein unspecific to the TAMs correlated with tumor growth, which might explain these discrepant effects of TAM subtypes on the EMT regulation of CRC. Here, CD68 is linked to colorectal carcinoma.